ALGN Stock Align Technology, Inc.
US · NasdaqGSLast in our picks 2026-10-15 — not in the current list; analysis below is from that screen
Clear-aligner penetration and product innovation offer cyclical recovery potential at discounted valuation.
Future value: $201.71 (+39.65%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Potential demand recovery, but current orthodontic spending remains uneven.
- ▾Below 50-day MA (-6.97%)
- ▸~40% upside to price target
Is ALGN a buy right now?
Trend: ALGN is trading above the 50-day average (+1.60%), RSI 42 — neutral momentum, with a 3-month return of -8.06%.
Valuation & quality: Align Technology, Inc. trades on a trailing P/E of 26.5, forward P/E 12.3, PEG 0.65, price-to-book 2.56; fundamentals show net margin 10.0%, return on equity 10.2%, revenue growth 4.3% year on year.
Analyst consensus: 14 analysts have a mean 12-month price target of $188.86 (+24% vs the last close; range $155.00 – $215.00), consensus rating “buy”.
Our screen: ACCUMULATE (score 1) — Clear-aligner penetration and product innovation offer cyclical recovery potential at discounted valuation.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -9.80% | +2.70% | -0.60% | -3.60% | +0.30% | -5.50% | -9.00% | +6.30% |
Fundamentals
Analyst price target
Technical signals
About Align Technology, Inc.
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.
Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 20,435 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.